210 related articles for article (PubMed ID: 10942602)
21. Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle.
Bresnahan WA; Boldogh I; Ma T; Albrecht T; Thompson EA
Cell Growth Differ; 1996 Oct; 7(10):1283-90. PubMed ID: 8891332
[TBL] [Abstract][Full Text] [Related]
22. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
[TBL] [Abstract][Full Text] [Related]
23. Stem cell factor inhibits erythroid differentiation by modulating the activity of G1-cyclin-dependent kinase complexes: a role for p27 in erythroid differentiation coupled G1 arrest.
Tamir A; Petrocelli T; Stetler K; Chu W; Howard J; Croix BS; Slingerland J; Ben-David Y
Cell Growth Differ; 2000 May; 11(5):269-77. PubMed ID: 10845428
[TBL] [Abstract][Full Text] [Related]
24. Mimosine arrests cells in G1 by enhancing the levels of p27(Kip1).
Wang G; Miskimins R; Miskimins WK
Exp Cell Res; 2000 Jan; 254(1):64-71. PubMed ID: 10623466
[TBL] [Abstract][Full Text] [Related]
25. Cell cycle. Order from destruction.
Bartek J; Lukas J
Science; 2001 Oct; 294(5540):66-7. PubMed ID: 11588240
[No Abstract] [Full Text] [Related]
26. Inhibition of Cdk2 activation by selected tyrphostins causes cell cycle arrest at late G1 and S phase.
Kleinberger-Doron N; Shelah N; Capone R; Gazit A; Levitzki A
Exp Cell Res; 1998 Jun; 241(2):340-51. PubMed ID: 9637776
[TBL] [Abstract][Full Text] [Related]
27. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
Nahum A; Hirsch K; Danilenko M; Watts CK; Prall OW; Levy J; Sharoni Y
Oncogene; 2001 Jun; 20(26):3428-36. PubMed ID: 11423993
[TBL] [Abstract][Full Text] [Related]
28. Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry.
Zhao J; Dynlacht B; Imai T; Hori T; Harlow E
Genes Dev; 1998 Feb; 12(4):456-61. PubMed ID: 9472014
[TBL] [Abstract][Full Text] [Related]
29. Both low and high concentrations of staurosporine induce G1 arrest through down-regulation of cyclin E and cdk2 expression.
Zong ZP; Fujikawa-Yamamoto K; Li AL; Yamaguchi N; Chang YG; Murakami M; Odashima S; Ishikawa Y
Cell Struct Funct; 1999 Dec; 24(6):457-63. PubMed ID: 10698260
[TBL] [Abstract][Full Text] [Related]
30. V3 loop of human immunodeficiency virus type 1 reduces cyclin E expression and induces G1 arrest in interleukin 2-dependent T cells.
Sakaida H; Kawamata S; Hattori T; Uchiyama T
AIDS Res Hum Retroviruses; 1998 Jan; 14(1):31-8. PubMed ID: 9453249
[TBL] [Abstract][Full Text] [Related]
31. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
Morris L; Allen KE; La Thangue NB
Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
[TBL] [Abstract][Full Text] [Related]
32. Cell cycle-regulated phosphorylation of p220(NPAT) by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription.
Ma T; Van Tine BA; Wei Y; Garrett MD; Nelson D; Adams PD; Wang J; Qin J; Chow LT; Harper JW
Genes Dev; 2000 Sep; 14(18):2298-313. PubMed ID: 10995387
[TBL] [Abstract][Full Text] [Related]
33. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
[TBL] [Abstract][Full Text] [Related]
34. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA
Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579
[TBL] [Abstract][Full Text] [Related]
35. Cytokine-induced phosphoinositide 3-kinase activity promotes Cdk2 activation in factor-dependent hematopoietic cells.
Henry MK; Nimbalkar D; Hohl RJ; Quelle FW
Exp Cell Res; 2004 Sep; 299(1):257-66. PubMed ID: 15302592
[TBL] [Abstract][Full Text] [Related]
36. Association of Cdk2/cyclin E and NF-kappa B complexes at G1/S phase.
Chen E; Li CC
Biochem Biophys Res Commun; 1998 Aug; 249(3):728-34. PubMed ID: 9731206
[TBL] [Abstract][Full Text] [Related]
37. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E.
Won KA; Reed SI
EMBO J; 1996 Aug; 15(16):4182-93. PubMed ID: 8861947
[TBL] [Abstract][Full Text] [Related]
38. Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cells.
Motwani M; Li X; Schwartz GK
Clin Cancer Res; 2000 Mar; 6(3):924-32. PubMed ID: 10741717
[TBL] [Abstract][Full Text] [Related]
39. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
Morris TA; DeLorenzo RJ; Tombes RM
Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994
[TBL] [Abstract][Full Text] [Related]
40. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
